CY339A - Naphthoxy-substituted alkanolamines - Google Patents

Naphthoxy-substituted alkanolamines

Info

Publication number
CY339A
CY339A CY33966A CY33966A CY339A CY 339 A CY339 A CY 339A CY 33966 A CY33966 A CY 33966A CY 33966 A CY33966 A CY 33966A CY 339 A CY339 A CY 339A
Authority
CY
Cyprus
Prior art keywords
naphthoxy
substituted alkanolamines
alkanolamines
substituted
Prior art date
Application number
CY33966A
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CY339A publication Critical patent/CY339A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58—Preparation of carboxylic acid halides
    • C07C51/60—Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY33966A 1962-11-23 1966-01-12 Naphthoxy-substituted alkanolamines CY339A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB44357/62A GB994918A (en) 1962-11-23 1962-11-23 Naphthoxy-substituted alkanolamines

Publications (1)

Publication Number Publication Date
CY339A true CY339A (en) 1966-01-12

Family

ID=10432900

Family Applications (1)

Application Number Title Priority Date Filing Date
CY33966A CY339A (en) 1962-11-23 1966-01-12 Naphthoxy-substituted alkanolamines

Country Status (13)

Country Link
US (2) US3337628A (de)
AT (3) AT244949B (de)
BE (1) BE640312A (de)
BR (1) BR6354781D0 (de)
CH (1) CH493463A (de)
CY (1) CY339A (de)
DE (1) DE1493847A1 (de)
DK (4) DK109992C (de)
ES (1) ES293736A1 (de)
FI (1) FI40904B (de)
GB (1) GB994918A (de)
MY (1) MY6600009A (de)
NL (1) NL300886A (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6504268A (de) * 1965-04-03 1966-10-04
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
US3959359A (en) * 1968-01-23 1976-05-25 Laboratoires Laroche Navarron Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
US3534084A (en) * 1968-10-16 1970-10-13 Squibb & Sons Inc Adamantylamino-naphthyloxypropanols and related compounds
SE372762B (de) * 1969-05-21 1975-01-13 Haessle Ab
US3961072A (en) * 1969-12-17 1976-06-01 Pfizer Inc. Phenoxypropanolamine therapeutic agents
US3996284A (en) * 1971-03-23 1976-12-07 Wijbe Thomas Nauta Naphthyl and tetrahydronaphthyl di-ethers
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer
DE2354444A1 (de) * 1973-10-31 1975-05-07 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4051186A (en) * 1974-06-20 1977-09-27 The Regents Of The University Of California Amino-propranolol
US4379167A (en) * 1974-10-25 1983-04-05 A. H. Robins Company, Inc. 1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4071552A (en) * 1976-05-19 1978-01-31 Ayerst Mckenna And Harrison Ltd. Aryloxy aminobutanols, their preparation and use thereof
US4201866A (en) * 1977-01-17 1980-05-06 American Home Products Corporation O-Hemi-succinate of propranolol
US4463190A (en) * 1977-07-05 1984-07-31 A. H. Robins Company, Inc. 1-Aryloxy-4-amino-2-butanols
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
US4241177A (en) * 1978-08-28 1980-12-23 Syva Company Propanolol antigen conjugates and antibodies
US4585785A (en) * 1979-01-09 1986-04-29 A. H. Robins Company, Inc. Cis and trans-3-aryloxy-4-hydroxypyrrolidines used as anti-arrhythmics
RO71464A2 (ro) * 1979-02-23 1981-05-15 Intreprinderea De Medicamente,Ro Procedeu pentru fabricarea 1-(1-naftoxi) 3-izopropilamino-2-propanolului
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
EP0025111B1 (de) * 1979-08-10 1984-07-25 Sandoz Ag 3-Aminopropoxyaryl-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4376125A (en) * 1980-11-05 1983-03-08 University Of Virginia Alumni Patents Foundation Aminobenzlpropranolol and pharmaceutical preparation thereof
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4321398A (en) * 1981-05-07 1982-03-23 Mead Johnson & Company Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
FR2521136A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
IT1212552B (it) * 1982-10-20 1989-11-30 Italo Britannica L Manet Ti H Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
NZ208337A (en) * 1983-06-10 1988-10-28 Bristol Myers Co 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
DE3330005A1 (de) * 1983-08-19 1985-02-28 Wolfgang Dr. Graz Lindner Weinsaeuremonoester von optisch aktiven alkanolaminen, verfahren zu ihrer herstellung und ihre verwendung
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JPS61210063A (ja) * 1985-03-14 1986-09-18 Mitsubishi Chem Ind Ltd アリ−ルスルホン類
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
US5387613A (en) * 1993-07-23 1995-02-07 Ribogene, Inc. Treatment of tachyarrhythmias of supraventricular origin
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
DK0759299T3 (da) * 1995-08-16 2000-08-07 Lilly Co Eli Potensering af serotoninrespons
US5776985A (en) * 1995-11-16 1998-07-07 The George Washington University Fluorinated propranolol and related methods
US5967613A (en) * 1997-08-11 1999-10-19 Piccard Corporation Wheelchair support and attachment system
GB0023467D0 (en) * 2000-09-25 2000-11-08 Btg Int Ltd Amine compounds
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US20060182806A1 (en) * 2004-11-08 2006-08-17 Mintong Guo Extended-release propranolol composition
AP2764A (en) * 2005-01-31 2013-09-30 Mylan Lab Inc Hydroxylated nebivolol metabolites
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
CA2680843C (en) * 2007-01-29 2016-05-31 Vlife Sciences Technologies Pvt. Ltd. Pharmaceutical composition for treatment of diabetic complications
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
EP2959904A1 (de) 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Verfahren zur Behandlung, Diagnose und Prognose einer hämatologischen Malignität
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3589327A4 (de) * 2017-03-03 2022-04-06 Synovo GmbH Neuartige antiinfektions- und entzündungshemmungsverbindungen
US11382875B2 (en) 2017-04-07 2022-07-12 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Methods and compositions for modulating β-amyloid/α7-nAChR interactions
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB622297A (en) * 1946-12-06 1949-04-29 British Drug Houses Ltd Improvements in or relating to the preparation of basic ethers
US3033640A (en) * 1954-06-16 1962-05-08 Saul & Co Incorporation of an organic basic compound into cellulose acetate materials
FR1198123A (fr) * 1958-06-02 1959-12-04 Rech S Biolog Soc D Procédé de préparation d'aryloxy-amino-alcools et de leurs dérivés (sels, esters, ammoniums quaternaires) et produits obtenus par la mise en oeuvre de ce procédé
GB1023214A (en) * 1962-12-17 1966-03-23 Ici Ltd Carbocyclic hydroxyamines
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
MY6600009A (en) 1966-12-31
DK109784C (da) 1968-07-01
ES293736A1 (es) 1964-03-01
GB994918A (en) 1965-06-10
AT244949B (de) 1966-02-10
DK109992C (da) 1968-08-19
FI40904B (de) 1969-03-31
DE1493847A1 (de) 1971-07-22
NL300886A (de)
BR6354781D0 (pt) 1973-07-12
DK111203B (da) 1968-07-01
AT246734B (de) 1966-05-10
AT244948B (de) 1966-02-10
BE640312A (de) 1964-05-22
DK111204B (da) 1968-07-01
US3520919A (en) 1970-07-21
CH493463A (de) 1970-07-15
US3337628A (en) 1967-08-22

Similar Documents

Publication Publication Date Title
MY6600009A (en) Naphthoxy-substituted alkanolamines
JPS5623021A (en) Flippflop unit
MY7000080A (en) Pyrazinamidoguanidines
MY7000094A (en) 4-hydroxybenzonitrile derivatives
MY6700099A (en) Substituted oxazolidinones
MY7000093A (en) 4-hydroxybenzonitrile derivatives
CY427A (en) Penicillins
IE26618L (en) Cyclodecene-5-one-1
IE26942L (en) 18-homo-steroids
IE27025L (en) Sulphapyrimidines
IE27027L (en) Sulphanilamido-pyrimidines
IE27071L (en) Aryl-amino-diazacyclopentenes
IE26940L (en) Pyrazinoyl-guanidines
YU32253B (en) Postupak dobijanja 17-alkilsteroid ketona
IE26909L (en) 6-chloro-steroids
IE26883L (en) 6-methyl-steroids
IE26790L (en) Dibenzocycloheptenes
IE26787L (en) Tetrahydronaphthyl - amino - imidazoline
IE26381L (en) 3-aminoalkyl-indoles
IE23939L (en) Keto-steroids
CA24775S (en) Type holder
CA24525S (en) Bottle
CA24689S (en) Bottle
IE26552L (en) Aminohydantoin derivatives
IE26949L (en) Benzenesulphonyl-urea derivatives